Michael R. Stabley

Array ( [id] => 4113114 [patent_doc_number] => 06046034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Thermostable variants of human interferon-.gamma.(IFN-.gamma.)' [patent_app_type] => 1 [patent_app_number] => 9/029819 [patent_app_country] => US [patent_app_date] => 1998-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5336 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046034.pdf [firstpage_image] =>[orig_patent_app_number] => 029819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140345 [patent_doc_number] => 06030795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Recombinant TGF-.beta. type I receptor variants having differentially diminished capacity to signal for matrix protein production' [patent_app_type] => 1 [patent_app_number] => 9/029424 [patent_app_country] => US [patent_app_date] => 1998-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5581 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030795.pdf [firstpage_image] =>[orig_patent_app_number] => 029424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4135858 [patent_doc_number] => 06015693 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Recombinant production of soluble TGF-.beta.-binding endoglin polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/047645 [patent_app_country] => US [patent_app_date] => 1998-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 7683 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015693.pdf [firstpage_image] =>[orig_patent_app_number] => 047645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360498 [patent_doc_number] => 06174996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Hybrid interferon .tau./type I interferon polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/045467 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 28137 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174996.pdf [firstpage_image] =>[orig_patent_app_number] => 045467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421968 [patent_doc_number] => 06177543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Recombinant lymphotoxin' [patent_app_type] => 1 [patent_app_number] => 9/044495 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 8 [patent_no_of_words] => 15867 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177543.pdf [firstpage_image] =>[orig_patent_app_number] => 044495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4362627 [patent_doc_number] => 06255459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Antibodies to a G protein-activated, inward rectifying KGA potassium channel' [patent_app_type] => 1 [patent_app_number] => 9/042494 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 10824 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255459.pdf [firstpage_image] =>[orig_patent_app_number] => 042494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173710 [patent_doc_number] => 06036949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Treatment of fibromyalgia with low doses of interferon' [patent_app_type] => 1 [patent_app_number] => 9/035290 [patent_app_country] => US [patent_app_date] => 1998-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6054 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/036/06036949.pdf [firstpage_image] =>[orig_patent_app_number] => 035290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187221 [patent_doc_number] => 06153407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Erythropoietin DNA having modified 5\' and 3\' sequences and its use to prepare EPO therapeutics' [patent_app_type] => 1 [patent_app_number] => 9/017631 [patent_app_country] => US [patent_app_date] => 1998-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 28 [patent_no_of_words] => 17538 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153407.pdf [firstpage_image] =>[orig_patent_app_number] => 017631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301491 [patent_doc_number] => 06187564 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'DNA encoding erythropoietin multimers having modified 5\' and 3\' sequences and its use to prepare EPO therapeutics' [patent_app_type] => 1 [patent_app_number] => 9/018138 [patent_app_country] => US [patent_app_date] => 1998-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 26 [patent_no_of_words] => 13333 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187564.pdf [firstpage_image] =>[orig_patent_app_number] => 018138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174195 [patent_doc_number] => 06083907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Treatment of peptic ulcers using midkine (MK) proteins' [patent_app_type] => 1 [patent_app_number] => 9/012084 [patent_app_country] => US [patent_app_date] => 1998-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4620 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083907.pdf [firstpage_image] =>[orig_patent_app_number] => 012084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943596 [patent_doc_number] => 05955069 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Use of canine interferon-.gamma.(IFN-.gamma.) to treat non-atopic dermatitis' [patent_app_type] => 1 [patent_app_number] => 9/001944 [patent_app_country] => US [patent_app_date] => 1997-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8988 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955069.pdf [firstpage_image] =>[orig_patent_app_number] => 001944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213553 [patent_doc_number] => 06087116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Interleukin-18 (IL-18) receptor polypeptides and their uses' [patent_app_type] => 1 [patent_app_number] => 8/996338 [patent_app_country] => US [patent_app_date] => 1997-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 25433 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087116.pdf [firstpage_image] =>[orig_patent_app_number] => 996338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174247 [patent_doc_number] => 06083910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Therapeutic uses of resolved intact or clipped native-sequence PDGF-BB dimers' [patent_app_type] => 1 [patent_app_number] => 8/989250 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9713 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083910.pdf [firstpage_image] =>[orig_patent_app_number] => 989250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4167350 [patent_doc_number] => 06140076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Ig superfamily `dlair` receptors expressed in monocytes' [patent_app_type] => 1 [patent_app_number] => 8/985950 [patent_app_country] => US [patent_app_date] => 1997-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48664 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140076.pdf [firstpage_image] =>[orig_patent_app_number] => 985950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213026 [patent_doc_number] => 06110695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1' [patent_app_type] => 1 [patent_app_number] => 8/982493 [patent_app_country] => US [patent_app_date] => 1997-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 11660 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110695.pdf [firstpage_image] =>[orig_patent_app_number] => 982493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150460 [patent_doc_number] => 06113900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Use of IL-2 receptor-targeted therapeutics to inhibit allograft rejection and treat autoimmune disorders' [patent_app_type] => 1 [patent_app_number] => 8/975563 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3921 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113900.pdf [firstpage_image] =>[orig_patent_app_number] => 975563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3909385 [patent_doc_number] => 06001604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Refolding of proinsulins without addition of reducing agents' [patent_app_type] => 1 [patent_app_number] => 8/967867 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 11068 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001604.pdf [firstpage_image] =>[orig_patent_app_number] => 967867 [rel_patent_id] =>[rel_patent_doc_number] =>)